» Articles » PMID: 33799580

Postbiotics, Metabolic Signaling, and Cancer

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2021 Apr 3
PMID 33799580
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Postbiotics are health-promoting microbial metabolites delivered as a functional food or a food supplement. They either directly influence signaling pathways of the body or indirectly manipulate metabolism and the composition of intestinal microflora. Cancer is the second leading cause of death worldwide and even though the prognosis of patients is improving, it is still poor in the substantial part of the cases. The preventable nature of cancer and the importance of a complex multi-level approach in anticancer therapy motivate the search for novel avenues of establishing the anticancer environment in the human body. This review summarizes the principal findings demonstrating the usefulness of both natural and synthetic sources of postbotics in the prevention and therapy of cancer. Specifically, the effects of crude cell-free supernatants, the short-chain fatty acid butyrate, lactic acid, hydrogen sulfide, and β-glucans are described. Contradictory roles of postbiotics in healthy and tumor tissues are highlighted. In conclusion, the application of postbiotics is an efficient complementary strategy to combat cancer.

Citing Articles

Delineating the nexus between gut-intratumoral microbiome and osteo-immune system in bone metastases.

Kapoor S, Gupta M, Sapra L, Kaur T, Srivastava R Bone Rep. 2024; 23:101809.

PMID: 39497943 PMC: 11532283. DOI: 10.1016/j.bonr.2024.101809.


Appraisal of postbiotics in cancer therapy.

Sudaarsan A, Ghosh A Front Pharmacol. 2024; 15:1436021.

PMID: 39372197 PMC: 11449718. DOI: 10.3389/fphar.2024.1436021.


Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing Nissle 1917 strain.

Falzone L, Lavoro A, Candido S, Salmeri M, Zanghi A, Libra M Gut Microbes. 2024; 16(1):2397874.

PMID: 39229962 PMC: 11376418. DOI: 10.1080/19490976.2024.2397874.


Modulation of Gut Microbial Biomarkers and Metabolites in Cancer Management by Tea Compounds.

Leung H, Lo E, Zhang F, Felicianna , Ismaiah M, Chen C Int J Mol Sci. 2024; 25(12).

PMID: 38928054 PMC: 11203446. DOI: 10.3390/ijms25126348.


Initiation of Apoptotic Pathway by the Cell-Free Supernatant Synthesized from Weissella cibaria Through In-Silico and In-Vitro Methods.

Manoharan M, Ragothaman P, Balasubramanian T Appl Biochem Biotechnol. 2023; 196(7):4700-4724.

PMID: 37751008 DOI: 10.1007/s12010-023-04688-3.


References
1.
Lambert D, Wood I, Ellis A, Shirazi-Beechey S . Molecular changes in the expression of human colonic nutrient transporters during the transition from normality to malignancy. Br J Cancer. 2002; 86(8):1262-9. PMC: 2375337. DOI: 10.1038/sj.bjc.6600264. View

2.
Tlaskalova-Hogenova H, Stepankova R, Kozakova H, Hudcovic T, Vannucci L, Tuckova L . The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol. 2011; 8(2):110-20. PMC: 4003137. DOI: 10.1038/cmi.2010.67. View

3.
Koukourakis M, Giatromanolaki A, Harris A, Sivridis E . Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res. 2006; 66(2):632-7. DOI: 10.1158/0008-5472.CAN-05-3260. View

4.
Wasser S, Weis A . Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol. 1999; 19(1):65-96. View

5.
Heidor R, Ortega J, de Conti A, Ong T, Moreno F . Anticarcinogenic actions of tributyrin, a butyric acid prodrug. Curr Drug Targets. 2012; 13(14):1720-9. DOI: 10.2174/138945012804545443. View